Peer Review reports
From: B.infantis enhances immunotherapy for Guillain-Barre syndrome through regulating PD-1
| Original Submission | ||
|---|---|---|
| 22 Dec 2021 | Submitted | Original manuscript |
| Resubmission - Version 2 | ||
| Submitted | Manuscript version 2 | |
| Resubmission - Version 3 | ||
| Submitted | Manuscript version 3 | |
| 4 May 2022 | Reviewed | Reviewer Report - Debprasad Dutta |
| 1 Dec 2022 | Reviewed | Reviewer Report - Weihua Jia |
| 5 Dec 2022 | Reviewed | Reviewer Report |
| 20 Dec 2022 | Author responded | Author comments - Di Nian |
| Resubmission - Version 4 | ||
| 20 Dec 2022 | Submitted | Manuscript version 4 |
| 22 Dec 2022 | Author responded | Author comments - Di Nian |
| Resubmission - Version 5 | ||
| 22 Dec 2022 | Submitted | Manuscript version 5 |
| 23 Dec 2022 | Reviewed | Reviewer Report - Debprasad Dutta |
| 26 Dec 2022 | Reviewed | Reviewer Report |
| 27 Dec 2022 | Reviewed | Reviewer Report - Weihua Jia |
| Resubmission - Version 6 | ||
| Submitted | Manuscript version 6 | |
| Publishing | ||
| 28 Dec 2022 | Editorially accepted | |
| 28 Jan 2023 | Article published | 10.1186/s12883-022-03046-w |
You can find further information about peer review here.